Development and Validation of a RP-HPLC for the Simultaneous Estimation of Atenolol and Hydrochlorothiazide in Pharmaceutical Dosage forms


  • K. B. Institute of Pharmaceutical Education and Research, Department of Pharmacognosy and Phytochemistry, Gandhinagar, Gujarat, 382 023, India


The reverse phase high performance liquid chromatography (RP-HPLC) method of Atenolol and Hydrochlorothiazide is individually available in United State of Pharmacopoeia-27 (USP-27) but no reference is available for combined estimation of Atenolol and Hydrochlorothiazide in tablets formulation. The aim of our present work was to develop a precise and validated RP-HPLC method for the simultaneous determination of Atenolol and Hydrochlorothiazide in tablets formulation. The quantification was carried out by using Zorbax SB-CN (250 x 4.6 mm), 5μm column in isocratic mode with mobile phase, Water: Buffer: Methanol (50:35:15). The flow rate was 1.2 ml/min. The peak purity of Atenolol and Hydrochlorothiazide were 0.999 and 1.000 respectively. Ruggedness and robustness of method were performed and the percentage relative standard deviation (RSD) was found below 2.0%. The percentage recovery was found in the range of 98% to 102% at three different levels. Calibration curves were linear over studies ranges with correlation co-efficient found between the range of 0.99 to 1.00. Sample and standard solution stability study was performed over 21 h at room temperature and found stable. The percentage deviation was below 2.0%.


Atenolol, Hydrochlorothiazide, RP - HPLC Method, Combination Tablets.

Subject Discipline

Pharmacy and Pharmacology

Full Text:


Os I, Hotens T, Dollerup J, Mogensen CE. Comparison of the Combination of Enalapril and a very low dose of Hydrochlorothiazide with Atenolol in-patients with mild-to-moderate Hypertension. Amer J Hypertens 1991; 10:899904.

Schmieder E. Telmisartan/hydrochlorothiazide combination therapy in the treatment of essential hypertension. Expert Opin Pharmacother 2004; 5:2303–10.

Collins R, Peto R, MacMohan S. Blood pressure, stroke and coronary hearth disease. Part 2, shortterm reduction in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335:827-38.

Suharmi S, Santoso B, Mulyono. Influence of atenolol on the pharma-cokinetics and diuretic effects of hydrochlorothiazide in healthy volunteers. Eur J Pharmacol 1990; 183:2375-76.

Vander Does R, Widmann L, Horrmann M, Machwirth M, Stienen U. Suppl. Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide. Eur J Pharmacol 1990; 38:147-152.

CVN Prasad, Parihar C, Sunil K, Parimoo P. Simultaneous determination of Amiloride HCL, hydrochlorothiazide and atenolol in combined formulation by derivative Spectroscopy. J Pharm Bio Anal 2004; 5:2303-10.

MCF Ferraro, Castellano PM, kaufmana TS. Chemometric determination of amiloride hydrochloride, atenolol, hydrochlorothiazide and timolol maleate in synthetic mixtures and pharmaceutical formulation. J Pharm Bio Anal 2004; 34:305-14

Parrissi-poulou M, Reizopolou V, Kouppans M, Machers P. Second derivative UV Spectrophotometric determination of hydrochlorothiazide and amiloride hydrochlorothiazide combination tablets. Int J Pharma 1989; 51:169-74

Annonymous, United States Pharmacopoeia (USP-27), Asian addition Published by the United States Pharmacopoeia Convention Inc, USA; 2004, p. 222-6.

Rapado-Martinez I, Garcia-Alvarez-Coque MC, Villanueva-Camanas RM. Performance of micellar mobile phases in reversed-phase chromatography for the analysis of pharmaceuticals containing beta-blockers and other antihypertensive drugs. Analyst 1996; 121:1677-82.

Reynolds JGF, Martindale. The Extra Pharmacopoeia, The Pharmaceutical Press, 29th ed, London, UK, 1989, pp. 783–785.

Annonymous, British Pharmacopoeia, Published by HMSO, London; 2008, p. 509-11.

Nevin Erk. Spectrophotometric analysis of Hydrochlorothiazide and Valsartan. Analytical Letters, 2002; 35: 283-302.

Bhushan R., Deepak Gupta, Shravan Kumar Singh. Liquid chromatographic separation and UV determination of certain antihypertensive agents. Biomed Chromato. 2005; 20:217-224.


  • There are currently no refbacks.